A smartphone-based app shows potential for measuring presbyopic addition, with strong correlation to clinical measurements.

Patients with glaucoma using fixed combination therapy may experience faster presbyopia progression than those using monotherapy.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

LENZ Therapeutics' aceclidine outshines Vuity for presbyopia with better safety and duration. Click for LENZ's market potential and revenue growth forecast.

Presbyopia is a ubiquitous visual disability of the aging eye, affecting an estimated 1.04 billion people globally. [1] Given the prevalence, an increasing emphasis has been placed on the ...

Johnson & Johnson is launching what it describes as the first and only daily disposable, multifocal and toric contact lens for people who have both astigmatism and presbyopia, where n | J&J said ...

Background A pilot eyecare programme aimed to address the urgent eye health needs of older Zanzibari craftswomen. We investigated the impact of correcting presbyopia on their subjective well-being ...

NDA submission includes efficacy and safety data for the first fixed-dose combination therapy from the world’s largest and longest study ever conducted in the presbyopia eye drop category ...

Eye-focused biotechs Tenpoint Therapeutics and Visus Therapeutics are joining forces, setting their sights on filing a new drug approval application next year for a presbyopia-correcting eye drop ...

LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.

A loud claim triggers curiosity about an old eye condition — presbyopia Following the announcement of a pharma company launching eye drops that would get reduce dependency on reading glasses ...

Presbyopia affects the eyes' ability to focus. This article discusses the symptoms and causes of presbyopia as well as treatment options, diagnosis, and more.